A carregar...
Endurance of erythrocyte series in chemotherapy
Hematopoietic bone marrow toxicity is most often the limiting factor for chemotherapy doses. Increasing the intensity of chemotherapy doses (higher doses or more frequent administration) would improve antitumor effects, but the hematological toxicity does not allow these dose increases. This study e...
Na minha lista:
| Publicado no: | Exp Ther Med |
|---|---|
| Main Authors: | , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
D.A. Spandidos
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7604759/ https://ncbi.nlm.nih.gov/pubmed/33149778 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/etm.2020.9344 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|